- Research article
- Open Access
Mindfulness-based stress reduction in Parkinson’s disease: a systematic review
BMC Neurology volume 17, Article number: 92 (2017)
Mindfulness based stress reduction (MBSR) is increasingly being used to improve outcomes such as stress and depression in a range of long-term conditions (LTCs). While systematic reviews on MBSR have taken place for a number of conditions there remains limited information on its impact on individuals with Parkinson’s disease (PD).
Medline, Central, Embase, Amed, CINAHAL were searched in March 2016. These databases were searched using a combination of MeSH subject headings where available and keywords in the title and abstracts. We also searched the reference lists of related reviews. Study quality was assessed based on questions from the Cochrane Collaboration risk of bias tool.
Two interventions and three papers with a total of 66 participants were included. The interventions were undertaken in Belgium (n = 27) and the USA (n = 39). One study reported significantly increased grey matter density (GMD) in the brains of the MBSR group compared to the usual care group. Significant improvements were reported in one study for a number of outcomes including PD outcomes, depression, mindfulness, and quality of life indicators. Only one intervention was of reasonable quality and both interventions failed to control for potential confounders in the analysis. Adverse events and reasons for drop-outs were not reported. There was also no reporting on the costs/benefits of the intervention or how they affected health service utilisation.
This systematic review found limited and inconclusive evidence of the effectiveness of MBSR for PD patients. Both of the included interventions claimed positive effects for PD patients but significant outcomes were often contradicted by other results. Further trials with larger sample sizes, control groups and longer follow-ups are needed before the evidence for MBSR in PD can be conclusively judged.
Parkinson’s disease (PD) is a chronic neurodegenerative disease generally conceptualised as affecting motor function . However, those with PD often face additional ‘non-motor symptoms’ (NMS), such as mental health comorbidities including depression and anxiety [2, 3]. These NMS have been associated with reduced quality of life in PD . Depression and anxiety can also exacerbate the symptoms of PD [2, 5]. Therefore it is important to consider how therapies that can treat the symptoms of anxiety and depression, and increase resilience to stress may be beneficial to PD patients in dealing with their condition. People with PD have been found to be open to non-pharmacological treatment interventions [6, 7].
Mindfulness based stress reduction (MBSR) is an approach which is increasingly being used on people with long-term conditions. MBSR was first conceptualized and used by Jon Kabat-Zinn  and was developed as a complementary intervention in a hospital setting to serve as a referral service to physicians and other health care providers for patients with chronic pain or multiple chronic conditions who were not responding sufficiently to standard treatments . MBSR and related approaches have also been associated with improvements for a range of conditions . Reviews have demonstrated improvements in symptoms amongst people with cancer [11, 12] pain [13, 14] cardiovascular disease , stroke  and multiple sclerosis . Improvements have included mental health outcomes, such as depression, stress and anxiety, as well as overall quality of life. Despite the potential benefits MBSR might have, no previous review has been undertaken to determine the effects of MBSR for the treatment of those with PD. Therefore, this systematic review aimed to determine the effectiveness of MBSR for patients suffering from PD.
A registered protocol (PROSPERO 2016: CRD42016035304) guided the conduct of this review , which is reported in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement .
Inclusion criteria were based on the study design, participants, interventions and outcomes (SPIO), as described below. SPIO is an adaptation of the PICO (Population, Interventions, Comparison, Outcomes) framework  https://library.med.nyu.edu/library/instruction/handouts/pdf/picohandout.pdf. Trials which solely focus on, or incorporate a mindfulness intervention as defined by the author were selected. The population was adults diagnosed with PD. As with many other mind-body interventions, mindfulness as a therapeutic intervention is inherently varied and heterogeneous. Thus different forms, duration and frequency of mindfulness interventions were included. We included both Randomised Controlled Trials (RCTs) and non-randomised controlled trials which reported quantitative outcomes. Finally, we only considered studies published in peer-reviewed journals in English, as evidence suggests that limiting studies in this way does not introduce significant bias but is associated with considerable resource savings .
Information sources and search strategy
The following databases were searched: CENTRAL (Cochrane), Medline, Embase, Amed, PsycINFO and CINAHL.
These databases were searched using a coMBSRnation of subject headings where available (such as MeSH) and key words relating to Mindfulness and PD. The search strategy was developed for use in Medline, and was amended for use in the other databases, using appropriate controlled vocabulary, Boolean operators and search symbols. The search was complemented by carrying out citation searches for included studies. We also scanned the reference lists of related reviews for potentially relevant papers.
Following de-duplication, bibliographic records (titles and abstracts) were downloaded into the Distiller software programme https://www.evidencepartners.com/products/distillersr-systematic-review-software/ Abstracts and full papers were screened against the inclusion criteria, by two reviewers working independently. Inter-reviewer disagreements were resolved by discussing whether the paper met the inclusion/exclusion criteria. If consensus between the reviewers was not possible, the decision was referred to a third party.
We used online data collection forms using Distiller SR software. Two independent researchers extracted data on study details (country of origin, inclusion/exclusion criteria, number of participants), participant details (mean age, % male, ethnicity, socio-economic status, smoking status and comorbidities), description of the intervention, and outcomes.
Assessment of methodological quality
We based assessment of quality on measures from the Cochrane collaboration tool for assessing bias  Quality was assessed in each of the included studies by the two researchers working independently. Methods of allocation concealment, randomisation procedure, dropout rate and whether there was evidence of selective outcome reporting were assessed by answering yes, no or unknown.
Meta-analysis was planned if sufficient homogeneous studies were available for statistical pooling. However, as only 2 studies (3 papers) were included and were of different designs with one reporting results compared to a control group and one having no control group, meta-analysis was not possible.
Our initial search identified 1336 papers. After title and abstract screening there were 15 papers for full paper review. Three papers from two interventions met our criteria and were included (see Fig. 1).
Description of included studies
The two studies included a total of 66 participants, with 27 and 39 participants per study respectively (see Table 1). They took place in the USA  and Belgium [24, 25]. The studies differed considerably in the nature and delivery of the intervention and the outcome measures used. One study was a randomised control trial and one a non-randomised trial. The studies were similar in the age profile of the participants with mean age ranging from 61.8 [24, 25] to 65.6 . Only one study reported the ethnicity of the participants and showed they were predominantly Caucasian . Both studies had a majority of men ranging from 51.9% [24, 25] to 58.3% .
Aims of the interventions
Cash et al.  was a pilot study of the feasibility and impact of an 8-week mindfulness-based group intervention on cognitive and emotional functioning for individuals with PD and their caregivers. The Picket et al. [24, 25] study produced two papers from the same intervention. The principal aim of one was to investigate structural changes on brain MRI using voxel based morphometry (VBM)  while the other investigated possible neurobehavioral and neuroplastic changes secondary to taking part in mindfulness training for individuals living with PD .
Description of interventions
A summary of the key components of the interventions is given in Table 2. Both studies used MBSR interventions that were based the original MBSR program developed at the University of Massachusetts. [23,24,25].
Adaptations to the standard 8-week long program plan were varied across the studies. One study used sessions of shorter duration i.e. 1.5 h  compared to the traditional 2.5 h. The Cash et al. study  also used a later timing for the retreat at 1 week after the eighth session; the retreat session also had a shorter duration, at half a day, than the 1-day format generally used for MBSR programs. In contrast, Pickut et al. offered no full day retreat [24, 25].
All studies offered psycho-education, mindful meditations (sitting meditation, walking meditation) and gentle yoga. Cash et al.  encouraged participants to modify techniques as needed to meet their personal needs and limitations, such as sitting in a chair or lying down to optimize physical comfort and safety, or practicing chair yoga rather than floor-based exercises if unable to get up safely from the floor . Both studies contained instructions for home study for the duration of the course [23,24,25].
Details of the quality appraisal of the included studies can be found in Table 3. Only one intervention had a control group (usual care) and was therefore the only study considered to have a correct randomisation procedure [24, 25]. Allocation concealment was also clear in this intervention. One study had a dropout rate greater than 20% . Both studies were adjudged not to have controlled appropriately for potential confounders in their analysis. In addition, study samples were relatively small in size, meaning that they were likely to be under-powered.
The impact on PD was measured by Pickut et al.  using the Unified Parkinson’s Disease Rating Scale (UPDRS) . The investigator scoring, including UPDRS motor scoring was performed by a movement disorders specialist who was blinded as to the study allocation arm of the participant in question. Each question has a 5-point scale, where 0 means an absence of symptoms and 5 represents the most severe symptoms. They found significant change was obtained for the UPDRS motor III score (F = 4.39, p < .05), demonstrating motor changes for the MBSR group (pre-M = 27.43 versus post-M = 21.93), while no significant changes could be obtained for the UC group (pre-M = 27.92 versus post-M = 29) . This revealed that after the MBSR a decrease of 5.5 (20.05%) points was found on the UPDRS motor score. Cash et al.  assessed non-motor function using the PD Non motor Symptoms Questionnaire  but found no significant differences.
Two of the studies assessed the impact on depression using two different measures [23, 28]. Cash et al.  used the Patient Health Questionnaire-9  and found that participants showed significant declines in their report of depression symptoms, F (1, 24) =6.31, p = .019, η2 = .21. However, Pickut et al.  used the Beck Depression Inventory (BDI)  and found no significant difference.
Quality of life measures
Both Cash et al.  and Pickut et al.  used the Parkinson’s disease questionnaire (PDQ-39)  which is a subjective questionnaire to assess quality of life in patients with PD. The questionnaire consists of 39 questions, which are divided into eight subscales (mobility, ADL, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort). Each question has a range from 0 (no problem) to 100 (continuous problem/unable to do it). Cash et al.  reported that significant improvements were seen on the emotional functioning, F (1, 25) =10.34, p = .004, η2 = .29, and cognitive functioning, F (1, 25) =4.50, p = .044, η2 = .15, subscales. Pickut et al.  found that a marginally significant interaction effect (F = 3.50, p = .07) was obtained for the Parkinson’s disease questionnaire (PDQ-39) pain score, suggesting an increase of 0.79 (10.53%) points for the MBSR group and a decrease of 0.69 (8.63%) for the usual care group. However, no significant changes were found for the overall (PDQ-39) score for either study.
Both Cash  and Pickut et al.  used Five Facet Mindfulness Questionnaire  (FFMQ) of 39 items; five domains of mindfulness “skills” are assessed: observing, describing, acting with awareness, non- judging of inner experience, and non-reactivity to inner experience. Items are rated on a 5-point Likert-type scale from “never or very rarely true” to “very often or always true.” The adding up of domain results in a total score gives an approximation of mindfulness “skills.” Cash et al.  found no significant changes. Picket et al.  found a significant interaction effect (F = 11.07, p < .01) was obtained for the FFMQ ‘observe’ facet of the scale indicating that for the MBSR group there was a significant increase after treatment (M = 27.29) in comparison with before treatment (M = 24.14). For the UC group, no difference was obtained between before (M = 23.69) and after treatment (M = 23.54). No significant effect was obtained for the other facets of the FFMQ.
Brain magnetic resonance imaging (MRI)
Picket et al.  evaluated the neuroplastic effects of MBSR on the brain using anatomical MRI scans, assessing voxel-based morphometry (VBM). T1-weighted data sets were segmented into gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF), using a unified tissue segmentation approach. For each individual patient, the registered baseline T1-weighted image was subtracted from the 8 weeks’ follow-up T1-weighted image to obtain images that represent changes over time for each patient. These subtracted images were then compared between both intervention groups using a T-test. MRI findings showed increased GMD in the MBSR group compared to the UC group overtime in the left and right hippocampi and a small region in the right amygdala. Whole brain analysis revealed a large cluster in the right caudate nucleus and a smaller cluster in the left caudate nucleus. Significant clusters were also found in the left occipital lobe at the lingual gyrus and cuneus, in the left thalamus and bilaterally in the tempero-parietal junction. However, increased GMD was found in the UC compared to the MBSR group in the anterior lobe and dentate nucleus of the left cerebellum.
This systematic review found only limited evidence that MBSRs can prove useful in PD patients due to the small number and nature of the studies that were eligible for inclusion. Both of the included interventions claimed positive effects for PD patients. These findings are also supported by a qualitative study of 12 people with PD which found that participation in a mindfulness-based intervention helped with making positive changes to coping responses and could benefit people with PD and was an acceptable form of group intervention.  However, where studies reported on similar outcomes, differences in results were found. Pickut et al.  found that the intervention improved PD outcomes in contrast to Cash et al.  who found no significant effects. Similarly, Pickut et al.  reported an improvement in mindfulness measured with the FFMQ but Cash et al.  found no significant changes with the same measure. Conversely, Cash et al.  reported an improvement in depression, but Pickut et al.  found no significant difference. Pickut et al.  found significantly increased grey matter density (GMD) in the MBSR group compared to the usual care group. However, the authors recognise that the effects of this signal increase need to be correlated with motor and non-motor symptoms of PD and until further studies verify this effect the evidence for beneficial effects for PD patients remains limited .
Methodological and quality differences between the included studies might explain some of the differences in results. Only one study [24, 25] used a control group (usual care) making it difficult to draw definite conclusions from the other study about the likley causal effect of the intervention and changes in outcomes found . Both studies where small in size, and only one was of reasonable quality [24, 25]. Adverse events and reasons for drop-outs were not reported. This is of concern as the safety of MBSR may be particularly important for PD patient due to the nature of their condition . There was also no reporting on the costs/benefit of the intervention. The studies that reported on ethnicity of the intervention subjects showed them to be largely Caucasian, while little information on the socio-economic status of the participants. Follow up periods were short, with both interventions recording results immediately post intervention, and thus beneficial impacts over a longer period of time could not be determined.
Since conducting our review a recent additional small exploratory RCT been published on an intervention that combined mindfulness with lifestyle education . This found limited evidence of effectiveness of the intervention on the primary outcome of well-being (Parkinson’s Disease Questionnaire; PDQ-39). The author’s concluded that a larger study was required.
Strength and limitations
This is the first review evaluating the effectiveness of MBSRs in PD patients and has been carried out rigorously. The limited number and design of the studies meant meta-analysis was not possible. The small number of studies also meant analysis of the possible effects of the different specific intervention components, such as shorter duration of the sessions and no full day retreat, was not possible.
This systematic review found inconclusive evidence of the effectiveness that MBSRs have for PD patients. Further trials with larger sample size, control groups and longer follow-up are needed before the evidence for MBSRs in PD can be conclusively judged.
Jankovic J. Parkinson’s disease: clinical features and diagnosis. Neurol Neurosurg Psychiatry. 2008;79:368–76.
Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M. Nonmotor symptoms in Parkinsons disease in 2012: relevant clinical aspects. Parkinsons Dis. 2012;15:198316.
Koerts J, Leenders KL, Koning M, Bouma A, van Beilen M. The assessment of depression in Parkinson’s disease. Eur J Neurol. 2008;15:487–92.
Simpson J, Lekwuwa G, Crawford T. Predictors of quality of life in people with Parkinson’s disease: evidence for both domain specific and general relationships. Disabil Rehabil. 2014;36(23):1964–70.
Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson’s disease. Exp Neurol. 2012;233(1):79–86.
Oehlberg K, Barg FK, Brown GK, Taraborelli D, Stern MB, Weintraub D. Attitudes regarding the etiology and treatment of depression in Parkinson’s disease: a qualitative study. J Geriatr Psychiatry Neurol. 2008;21:123–32.
Wang Y, Xie C-L, Wang W-W, et al. Epidemiology of complementary and alternative medicine use in patients with Parkinson’s disease. J Clin Neurosci. 2013;20(8):1062–7.
Kabat-Zinn J, Lipworth L, Burney R, Sellers W. Four year follow-up of a meditation-based program for the self regulation of chronic pain: treatment outcomes and compliance. Clin J Pain. 1986;2(3):159–73.
Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8:163–90.
Gotink RA, Chu P, Busschbach JJ, Benson H, Fricchione GL, Hunink MG. Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs. PLoS One. 2015;10(4):e0124344.
Piet J, Wurtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012;80:1007–20.
Smith JE, Richardson J, Hoffman C, Pilkington K. Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs. 2005;52:315–27.
Veehof MM, Oskam MJ, Schreurs KMG, Bohlmeijer ET. Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain. 2011;152:533–42.
Kozasa EH, Tanaka LH, Monson C, Little S, Leao FC, et al. The effects of meditation-based interventions on the treatment of fibromyalgia. Curr Pain Headache 2012, Rep 16: 383–387.
Abbott RA, Whear R, Rodgers LR, Bethel A, Thompson Coon J, et al. Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: a systematic review and meta-analysis of randomised controlled trials. J Psychosom Res. 2014;76:341–51.
Lawrence M, Booth J, Mercer S, Crawford E. A systematic review of the benefits of mindfulness-based interventions following transient ischaemic attack and stroke. Int J Stroke. 2013;8:465–74.
Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis--a systematic review. BMC Neurol. 2014;14:15.
McLean G, Mercer S, Lawrence M. Mindfulness based stress reduction in Parkinson’s disease. PROSPERO 2016: CRD42016035304.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995 Nov–Dec;123(3):A12–3.
Moher D, Pham B, Lawson ML, Klassen TP. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess. 2003;7:1–90.
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group. Cochrane statistical methods group: the Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Cash TV, Ekouevi VS, Kilbourn C, Lageman SK. Pilot study of a mindfulness-based group intervention for individuals with Parkinson’s disease and their caregivers. Mindfulness. 2016;7:361–71.
Pickut BA, Van Hecke W, Kerckhofs E, et al. Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: a randomized controlled longitudinal trial. Clin Neurol Neurosurg. 2013;115(12):2419–25.
Pickut B, Vanneste S, Hirsch MA, Van Hecke W, Kerckhofs E, Mariën P, Parizel PM, Crosiers D, Cras P. Mindfulness training among individuals with Parkinson's disease: neurobehavioral effects. Park Dis. 2015;2015:816404.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the unified Parkinson’s disease Rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.
Chaudhuri K, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The non declaration of non motor symptoms of Parkinson’s disease to health care professionals: an international study using the non motor symptoms questionnaire. Mov Disord. 2010;25:704–9.
De la Fuente-Fernandez R, Schulzer M, Stoessl AJ. The placebo effect in neurological disorders. Lancet Neurol. 2002;1:85–91.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Levin BE, Llabre MM, Weiner WJ. Parkinson’s disease and depression: psychometric properties of the Beck depression Inventory. J Neurol Neurosurg Psychiatry. 1988;51(11):1401–4.
Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–7.
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134–9.
Baer R, Smith G, Hopkin J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13(1):27–45.
Fitzpatrick L, Simpson J, Smith A, “A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease,” Psychol Psychother 2010, vol. 83, part 2, pp. 179–192.
Lustyk M, Chawla N, Nolan R, Marlatt G. Mindfulness meditation research: issues of participant screening, safety procedures, and researcher training. Adv Mind Body Med. 2009;24:20–30.
Advocat J, Enticott J, Vandenberg B, Hassed C, Hester J, Russell G. The effects of a mindfulness-based lifestyle program for adults with Parkinson’s disease: a mixed methods, wait list controlled randomised control study. BMC Neurol. 2016;16:166.
We would like to thank the RS McDonald Trust for funding this study.
RS McDonald Trust.
Availability of data and materials
We do not hold any original data as this is a review article.
SWM conceived the study. ML carried out the literature searches. GM led the review process including data extraction and wrote the first draft of the paper. RS helped with the data extraction. All authors contributed to the writing of the final version of the paper. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Not applicable. This study is a systematic review of published papers and does not contain any individual person’s data.
Ethics approval and consent to participate
Not applicable. This study is a systematic review of published papers and as such did not require ethical approval or any consent.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
McLean, G., Lawrence, M., Simpson, R. et al. Mindfulness-based stress reduction in Parkinson’s disease: a systematic review. BMC Neurol 17, 92 (2017). https://doi.org/10.1186/s12883-017-0876-4
- Parkinson’s Disease
- Systematic Review
- Quality of Life